381 related articles for article (PubMed ID: 20561554)
1. Multiple aberrations in shared inflammatory and oxidative & nitrosative stress (IO&NS) pathways explain the co-association of depression and cardiovascular disorder (CVD), and the increased risk for CVD and due mortality in depressed patients.
Maes M; Ruckoanich P; Chang YS; Mahanonda N; Berk M
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):769-83. PubMed ID: 20561554
[TBL] [Abstract][Full Text] [Related]
2. An intriguing and hitherto unexplained co-occurrence: Depression and chronic fatigue syndrome are manifestations of shared inflammatory, oxidative and nitrosative (IO&NS) pathways.
Maes M
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):784-94. PubMed ID: 20609377
[TBL] [Abstract][Full Text] [Related]
3. A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness.
Maes M; Galecki P; Chang YS; Berk M
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):676-92. PubMed ID: 20471444
[TBL] [Abstract][Full Text] [Related]
4. Why myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) may kill you: disorders in the inflammatory and oxidative and nitrosative stress (IO&NS) pathways may explain cardiovascular disorders in ME/CFS.
Maes M; Twisk FN
Neuro Endocrinol Lett; 2009; 30(6):677-93. PubMed ID: 20038921
[TBL] [Abstract][Full Text] [Related]
5. Comorbidity between depression and inflammatory bowel disease explained by immune-inflammatory, oxidative, and nitrosative stress; tryptophan catabolite; and gut-brain pathways.
Martin-Subero M; Anderson G; Kanchanatawan B; Berk M; Maes M
CNS Spectr; 2016 Apr; 21(2):184-98. PubMed ID: 26307347
[TBL] [Abstract][Full Text] [Related]
6. The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression.
Maes M
Neuro Endocrinol Lett; 2008 Jun; 29(3):287-91. PubMed ID: 18580840
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression.
Leonard B; Maes M
Neurosci Biobehav Rev; 2012 Feb; 36(2):764-85. PubMed ID: 22197082
[TBL] [Abstract][Full Text] [Related]
8. The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression.
Maes M; Leonard BE; Myint AM; Kubera M; Verkerk R
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):702-21. PubMed ID: 21185346
[TBL] [Abstract][Full Text] [Related]
9. Schizophrenia is primed for an increased expression of depression through activation of immuno-inflammatory, oxidative and nitrosative stress, and tryptophan catabolite pathways.
Anderson G; Maes M; Berk M
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Apr; 42():101-14. PubMed ID: 22930036
[TBL] [Abstract][Full Text] [Related]
10. In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&NS), and autoimmune responses directed against O&NS-damaged neoepitopes.
Maes M; Kubera M; Leunis JC; Berk M; Geffard M; Bosmans E
Acta Psychiatr Scand; 2013 May; 127(5):344-54. PubMed ID: 22900942
[TBL] [Abstract][Full Text] [Related]
11. In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression.
Kubera M; Obuchowicz E; Goehler L; Brzeszcz J; Maes M
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):744-59. PubMed ID: 20828592
[TBL] [Abstract][Full Text] [Related]
12. Lower plasma Coenzyme Q10 in depression: a marker for treatment resistance and chronic fatigue in depression and a risk factor to cardiovascular disorder in that illness.
Maes M; Mihaylova I; Kubera M; Uytterhoeven M; Vrydags N; Bosmans E
Neuro Endocrinol Lett; 2009; 30(4):462-9. PubMed ID: 20010493
[TBL] [Abstract][Full Text] [Related]
13. Depression's multiple comorbidities explained by (neuro)inflammatory and oxidative & nitrosative stress pathways.
Maes M; Kubera M; Obuchowiczwa E; Goehler L; Brzeszcz J
Neuro Endocrinol Lett; 2011; 32(1):7-24. PubMed ID: 21407167
[TBL] [Abstract][Full Text] [Related]
14. New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.
Maes M; FiĊĦar Z; Medina M; Scapagnini G; Nowak G; Berk M
Inflammopharmacology; 2012 Jun; 20(3):127-50. PubMed ID: 22271002
[TBL] [Abstract][Full Text] [Related]
15. A neuro-immune, neuro-oxidative and neuro-nitrosative model of prenatal and postpartum depression.
Roomruangwong C; Anderson G; Berk M; Stoyanov D; Carvalho AF; Maes M
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():262-274. PubMed ID: 28941769
[TBL] [Abstract][Full Text] [Related]
16. Shared metabolic and immune-inflammatory, oxidative and nitrosative stress pathways in the metabolic syndrome and mood disorders.
de Melo LGP; Nunes SOV; Anderson G; Vargas HO; Barbosa DS; Galecki P; Carvalho AF; Maes M
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Aug; 78():34-50. PubMed ID: 28438472
[TBL] [Abstract][Full Text] [Related]
17. Basic mechanisms behind the effects of n-3 fatty acids on cardiovascular disease.
Massaro M; Scoditti E; Carluccio MA; De Caterina R
Prostaglandins Leukot Essent Fatty Acids; 2008; 79(3-5):109-15. PubMed ID: 18951002
[TBL] [Abstract][Full Text] [Related]
18. Oxidative & nitrosative stress in depression: why so much stress?
Moylan S; Berk M; Dean OM; Samuni Y; Williams LJ; O'Neil A; Hayley AC; Pasco JA; Anderson G; Jacka FN; Maes M
Neurosci Biobehav Rev; 2014 Sep; 45():46-62. PubMed ID: 24858007
[TBL] [Abstract][Full Text] [Related]
19. Psychophysiological and cortisol responses to psychological stress in depressed and nondepressed older men and women with elevated cardiovascular disease risk.
Taylor CB; Conrad A; Wilhelm FH; Neri E; DeLorenzo A; Kramer MA; Giese-Davis J; Roth WT; Oka R; Cooke JP; Kraemer H; Spiegel D
Psychosom Med; 2006; 68(4):538-46. PubMed ID: 16868262
[TBL] [Abstract][Full Text] [Related]
20. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation.
Maes M; Mihaylova I; Ruyter MD; Kubera M; Bosmans E
Neuro Endocrinol Lett; 2007 Dec; 28(6):826-31. PubMed ID: 18063923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
